Using human iPSC-derived cells to revolutionize the field of neurodegenerative disease

In this interview, we speak to Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,Manchester ,Jonathan Milner ,Yichen Shi ,Rattiya Thongdumhyu Shutterstock ,Axol Bioscience ,Axol Bioscience Ltdnov ,Jan Bruder Shutterstock ,Axol Biosciences ,Steven Broadbent ,Cambridge University ,European Union Horizon ,Roslin Institute In Edinburgh ,Manchester University ,Innovation Program ,Sponsored Content ,Censo Biotechnologies ,Senior Scientific Support Manager ,Sian Humphries ,Project Manager ,Roslin Institute ,Neuroburst Orange Lentivirus ,Sian Humphreys ,Neurodegenerative Disease ,Essay ,Iochemistry ,Fell ,Cell Line ,Cloning ,Cosmetics ,Drug Discovery ,Maging ,N Vivo ,Motor Neurons ,Muscle ,Neural Stem Cells ,Euron ,Eurons ,Neuroscience ,Reclinical ,Eagents ,Research ,Stem Cells ,